105-Year-Old Living On Prayers And Gin-Soaked Raisins - Across America, US - FDA analysis confirms safety and efficacy of single-shot Johnson & Johnson vaccine; business executives sign on to Biden relief plan.
Questions remain on J&J Covid-19 vaccine rollout as authorization decision approaches
Johnson & Johnson says that it has 4 million doses of its Covid-19 vaccine ready to ship “immediately” once it receives emergency use authorization, which could happen this week. But as the decision nears, it’s unclear when or where those doses will be delivered.
During a briefing on Wednesday, White House Covid coordinator Jeff Zients said the J&J vaccine’s distribution would be similar to the current allocations process across jurisdictions, pharmacies and community health centers. When asked earlier in the week, the White House did not disclose its plans, although an administration official said they have worked closely with the company to formulate a distribution outline.
FDA advisers to consider recommending single-dose Johnson & Johnson COVID-19 vaccine this week wktv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wktv.com Daily Mail and Mail on Sunday newspapers.
Font Size:
Republican Washington Rep. Cathy McMorris Rodgers said that efforts to censor certain conservative networks “sounds like actions from the Chinese Communist Party” during a House hearing on “disinformation and extremism in the media” Wednesday.
The House Committee on Energy & Commerce held a hearing titled “Fanning the Flames: Disinformation and Extremism in the Media,” which saw lawmakers and witnesses debate whether conservative networks like Newsmax, One America News Network and Fox News should be taken off the air due to coverage that some Democrats claim led to violence.
Rodgers began by ripping House Democrats’ efforts to pressure big tech into censoring conservative media during her opening statement.
FDA advisers to consider EUA recommendation for single-dose Johnson & Johnson Covid-19 vaccine this week
Vaccine advisers to the US Food and Drug Administration will meet Friday to discuss whether to recommend Johnson & Johnson’s Covid-19 vaccine for emergency use authorization.
The vaccine is the third under consideration for the US market, and would be the first single-dose Covid-19 shot available here. Like the earlier Covid-19 vaccines, it was developed and tested at a remarkable pace, condensing into months what might have taken years before the pandemic.
But there are few answers on what will happen if and when it is authorized. The White House said Monday it has not made any plans yet for distributing the vaccine if it wins authorization. There are vague totals of how many doses will be available immediately and no word on exactly where those doses will go.